MAPT and Alzheimer disease: Using a mouse model of tauopathy, scientists have observed that under glucose-deprived conditions as observed in hypometabolic AD brains, transgenic mice had impaired memory and reduced LTP accompanied by tau hyperphosphorylation and apoptosis (Lauretti et al., 2017).